SIU 2020 40th Congress of the International Society of Urology
SIU 2020 GU Malignancies - Prostate
- SIU Virtual Congress 2020: Germline and Somatic Mutations in Advanced Prostate Cancer: Actionable Targets
- SIU Virtual Congress 2020: Liquid Biopsy in Prostate Cancer, Where are We Now?
- SIU Virtual Congress 2020: Advantages and Limitations of PSMA-PET
- SIU Virtual Congress 2020: Is Serum PSA Still a Standard Marker for Prostate Cancer: Do We Have Game Changers?
- SIU Virtual Congress 2020: The Role of Genomic Testing in Prostate Cancer
SIU 2020 GU Malignancies Non-Prostate
- SIU Virtual Congress 2020: Benefits of MDT Approach for Patients Receiving Treatment with Anti PD Agents, and the Role of Anti-PD1 Agents in the Management of Locally Advanced and Metastatic Bladder Cancer
- SIU Virtual Congress 2020: Background on Bladder Cancer and Introduction to Anti-PD1 Agents
- SIU Virtual Congress 2020: New Perspectives in the Management of Invasive Upper Urinary Tract Urothelial Carcinoma
- SIU Virtual Congress 2020: Controversies in the Management of Small Renal Masses
- SIU Virtual Congress 2020: Debate: Is There Still a Role for Cytoreductive Nephrectomy in the Management of Kidney Cancer? For
SIU 2020 Telemedicine
- SIU Virtual Congress 2020: Developing Teleurology in Medical Education and Patient Care in Own Practice and World-Wide Opportunities and Challenges
- SIU Virtual Congress 2020: Regulatory and Medicolegal Considerations Surrounding the Provision of E-Health, Telemedicine in Various Groups: Re-Imbursement for Services Delivered by Telehealth/Telemedicine
- SIU Virtual Congress 2020: Various Models Available for Adoption in Telehealth/Telemedicine with Emphasis on Mobile Health Technology
- SIU Virtual Congress 2020: Definitions, Historical Aspects; Various Services that can be Provided Through Telemedicine; e-health; Health Informatics; AI, Robotics